We also analyzed the correlation between AURKB expression and clinicopathological parameters in 103 patients and found that AURKB expression was associated with serum CA19-9 level, tumor number, and lymph node metastasis. This evidence concerns the gene AURKB and metastatic malignant neoplasm in the lymph nodes.